{"id":"NCT02738333","sponsor":"Gilead Sciences","briefTitle":"Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV Infection","officialTitle":"A Phase 3b, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 2 HCV Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-04-12","primaryCompletion":"2017-02-14","completion":"2017-05-11","firstPosted":"2016-04-14","resultsPosted":"2018-03-14","lastUpdate":"2018-11-16"},"enrollment":239,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C Virus Infection"],"interventions":[{"type":"DRUG","name":"LDV/SOF","otherNames":["Harvoni®","GS-5885/GS-7977"]},{"type":"DRUG","name":"SOF","otherNames":["Sovaldi®","GS-7977","PSI-7977"]},{"type":"DRUG","name":"RBV","otherNames":["REBETOL®"]}],"arms":[{"label":"LDV/SOF (Cohort 1)","type":"EXPERIMENTAL"},{"label":"SOF+RBV (Cohort 1)","type":"EXPERIMENTAL"},{"label":"LDV/SOF (Cohort 2)","type":"EXPERIMENTAL"}],"summary":"The primary objectives of this study are to evaluate the antiviral efficacy of therapy with ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) and to evaluate the safety and tolerability of LDV/SOF FDC and sofosbuvir (SOF) + ribavirin (RBV) in participants with chronic genotype 2 hepatitis C virus (HCV) infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12)","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"LDV/SOF (Cohort 1)","deltaMin":96.2,"sd":null},{"arm":"SOF+RBV (Cohort 1)","deltaMin":95.4,"sd":null},{"arm":"LDV/SOF (Cohort 2)","deltaMin":96,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":37,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":106},"commonTop":["Viral upper respiratory tract infection","Anaemia","Headache","Stomatitis","Pyrexia"]}}